Medmira Stock Shares Owned By Institutions
MIR Stock | CAD 0.08 0.00 0.00% |
MedMira fundamentals help investors to digest information that contributes to MedMira's financial success or failures. It also enables traders to predict the movement of MedMira Stock. The fundamental analysis module provides a way to measure MedMira's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MedMira stock.
MedMira | Shares Owned By Institutions |
MedMira Company Shares Owned By Institutions Analysis
MedMira's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
MedMira Shares Owned By Institutions Driver Correlations
Understanding the fundamental principles of building solid financial models for MedMira is extremely important. It helps to project a fair market value of MedMira Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since MedMira's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MedMira's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MedMira's interrelated accounts and indicators.
Click cells to compare fundamentals
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 0.0% of MedMira are shares owned by institutions. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The shares owned by institutions for all Canada stocks is 100.0% higher than that of the company.
MedMira Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MedMira's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MedMira could also be used in its relative valuation, which is a method of valuing MedMira by comparing valuation metrics of similar companies.MedMira is currently under evaluation in shares owned by institutions category among its peers.
MedMira Current Valuation Drivers
We derive many important indicators used in calculating different scores of MedMira from analyzing MedMira's financial statements. These drivers represent accounts that assess MedMira's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of MedMira's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 276.5M | 79.0M | 88.5M | 62.8M | 56.5M | 33.0M | |
Enterprise Value | 288.0M | 92.8M | 96.7M | 72.0M | 64.8M | 39.9M |
MedMira Fundamentals
Return On Asset | -0.26 | ||||
Operating Margin | (7.40) % | ||||
Current Valuation | 60.09 M | ||||
Shares Outstanding | 701.73 M | ||||
Shares Owned By Insiders | 68.95 % | ||||
Number Of Shares Shorted | 979 | ||||
Price To Earning | (5.00) X | ||||
Price To Sales | 146.45 X | ||||
Revenue | 432.53 K | ||||
Gross Profit | (512.51 K) | ||||
EBITDA | (1.58 M) | ||||
Net Income | (2.68 M) | ||||
Cash And Equivalents | 1.06 K | ||||
Total Debt | 9.27 M | ||||
Current Ratio | 0.02 X | ||||
Book Value Per Share | (0.02) X | ||||
Cash Flow From Operations | (1.27 M) | ||||
Short Ratio | 0.02 X | ||||
Earnings Per Share | (0.01) X | ||||
Beta | 10.73 | ||||
Market Capitalization | 56.14 M | ||||
Total Asset | 3.65 M | ||||
Retained Earnings | (97.96 M) | ||||
Working Capital | (14.03 M) | ||||
Net Asset | 3.65 M |
About MedMira Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MedMira's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MedMira using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MedMira based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedMira Stock Analysis
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.